About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
Not Voodoo

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
Realizations in Biostatistics
ChemSpider Blog
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Eye on FDA
Chemical Forums
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa

Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
Gene Expression (I)
Gene Expression (II)
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net

Medical Blogs
DB's Medical Rants
Science-Based Medicine
Respectful Insolence
Diabetes Mine

Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem

Politics / Current Events
Virginia Postrel
Belmont Club
Mickey Kaus

Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Udo Opperman At The Challenges in Chemical Biology Conference | Main | Those Fortunate Onyx Option Traders »

July 24, 2013

GSK Scandal Info

Email This Entry

Posted by Derek

Several comments to the posts on the GSK China problems seem quite. . .knowledgable. This has inspired a journalist to get in touch with me, but I've told her that (since these comments are anonymous) that I have no way of verifying their contents or getting in touch with the people who left them. She is, however, interested in hearing from people with knowledge of the situation, and has left a comment to that effect on the most recent post. I'm standing out of the way on this one; I merely note that the request is out there. Readers and commenters are free to use their own best judgment about what, if anything, to do about it.

Comments (3) + TrackBacks (0) | Category: The Dark Side


1. bad wolf on July 24, 2013 4:52 PM writes...

On a completely unrelated topic, didn't Chinese hackers compromise the New York Times reporters investigating Chinese corruption, trying to find their sources?

Permalink to Comment

2. Enonimoose on July 25, 2013 4:58 AM writes...

@1: Almost certainly. They've broken into practically every sizable Silicon Valley company trying to gain login credentials and/or other correlating info of their dissidents. That's what they did at Yahoo and Google, at very least.

Permalink to Comment

3. Dan on July 27, 2013 8:41 AM writes...

I used the enjoy reading this blog much more when the author talked about things he actually knew about first hand: medicinal chemistry, drug discovery, and bench work. It is that first hand intimate understanding that makes reports authentic and enjoyable reads.

However, people who become successful, or maybe when people get older, I don't why, they feel entitled to opine about topics outside of their expertise and knowledge. The opinions come off as uninformed and often arrogant.

I have watched this blog change over the years. The percentage of topics has been shifting away from med chem and drug discovery. I don't know if this is because the author is in a new job since moving from B* to V* or maybe it is just a case of getting older or feeling more successful as a blogger. I wish there was a return to topics where the author is a true expert with intimate, first hand experience.

Permalink to Comment


Remember Me?


Email this entry to:

Your email address:

Message (optional):

The Last Post
The GSK Layoffs Continue, By Proxy
The Move is Nigh
Another Alzheimer's IPO
Cutbacks at C&E News
Sanofi Pays to Get Back Into Oncology
An Irresponsible Statement About Curing Cancer
Oliver Sacks on Turning Back to Chemistry